Fermenta Biotech Limited (NSE:FERMENTA)

India · Delayed Price · Currency is INR

301.25

+4.00 (1.35%)

At close: May 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Bulk Drugs/chemicals	4.00B	2.59B	2.80B	3.85B	3.60B
Bulk Drugs/chemicals Growth	54.50%	-7.29%	-27.43%	7.07%	30.61%
Property	544.02M	737.42M	630.34M	166.00M	176.29M
Property Growth	-26.23%	16.99%	279.73%	-5.84%	-10.20%
Unallocated	264.06M	145.20M	159.22M	-	-
Unallocated Growth	81.86%	-8.80%	-	-	-
Inter-Segment	-	-	-	-1.80M	-1.80M
Total	4.81B	3.47B	3.59B	4.02B	3.77B
Total Growth	38.51%	-3.09%	-10.74%	6.47%	28.84%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	2.19B	1.82B	1.67B	1.45B	1.06B
India Growth	19.90%	9.13%	14.93%	37.16%	4.38%
Europe	1.15B	571.19M	681.99M	1.03B	1.18B
Europe Growth	101.14%	-16.25%	-34.06%	-12.17%	36.37%
USA	725.60M	372.88M	418.78M	493.65M	590.20M
USA Growth	94.59%	-10.96%	-15.16%	-16.36%	96.59%
Others Countries	752.53M	707.45M	813.97M	1.08B	945.28M
Others Countries Growth	6.37%	-13.09%	-24.98%	14.77%	25.96%
Total	4.81B	3.47B	3.59B	4.07B	3.77B
Total Growth	38.51%	-3.09%	-11.83%	7.78%	28.79%

Source: S&P Global Market Intelligence.